CF
VRCA icon

Corebridge Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

Corebridge Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,980
Closed -$8.76K – 2725
2025
Q1 		$8.76K Buy
1,980
+1,039
+110% +$6.72K ﹤0.01% 2979
2024
Q4 		$6.59K Sell
941
-71
-7% -$780 ﹤0.01% 3016
2024
Q3 		$14.7K Sell
1,012
-7
-0.7% -$315 ﹤0.01% 2997
2024
Q2 		$74.3K Buy
+1,019
New +$78.3K ﹤0.01% 2761

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Corebridge Financial's VRCA Position: Q2 2025 in Review

Corebridge Financial sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 1,980 shares — an estimated $8.76K sold.

Corebridge Financial first reported a position in VRCA in Q2 2024 and held it in 4 quarters. The position peaked at $74.3K in Q2 2024. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Corebridge Financial reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 1,980 Verrica Pharmaceuticals shares in Q2 2025, an estimated $8.76K.
  • Corebridge Financial first reported a position in Verrica Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Verrica Pharmaceuticals position peaked at $74.3K in Q2 2024.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.